
Reset all filters
01 1AstraZeneca Canada Inc.
Reset all filters
01 12778714
Reset all filters
01 1DURVALUMAB
Reset all filters
01 1SOLUTION
Reset all filters
01 12030-11-24
Patent Expiration Date : 2030-11-24
Date Granted : 2018-02-27
Brand Name : IMFINZI
Patent Number : 2778714
Filing Date : 2010-11-24
Strength per Unit : 50mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2030-11-24
Date Granted : 2018-02-27
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF